Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-04-20 @ 6:54 AM
Study NCT ID:
NCT02255656
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2014-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-30
First Submit QC Date:
None
Study First Post Date:
2014-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-30
Results First Submit QC Date:
None
Results First Post Date:
2021-07-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-21
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL